Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Industry Insights
  • Page 3

Category: Industry Insights

Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.

argenx Unnatural Products acquisition infographic: $550M upfront, $595M milestones, oral peptides
  • Industry Insights

argenx Unnatural Products Acquisition: Inside the $1.15B Bet on Oral Peptides

Megan Wood6 days ago09 mins

argenx will buy Unnatural Products for up to $1.15B ($550M upfront) to own an oral macrocyclic peptide platform. Terms, strategy, risks and market context.

Read More
Healthcare startup investment India analysis for October 2026 funding data
  • Industry Insights

India Healthcare and Life-Sciences Startups Raised a Reported $173 Million Across 19 Rounds in October 2026

Megan Wood2 weeks ago010 mins

How to read healthcare startup investment India data for October 2026: a reported $173 million, concentration in one deal and why trackers disagree.

Read More
Apollo Hospitals revenue growth in Q2 FY27 and what the bed expansion means for margins
  • Industry Insights

Apollo Hospitals Q2 FY27 Results: Net Profit Rises 32% as Revenue Grows 23%

Megan Wood2 weeks ago011 mins

Why Apollo Hospitals revenue rose 23% in Q2 FY27, how profit and occupancy compare, and what the 5,800-bed plan means for margins and returns.

Read More
Early cancer detection: NHS STRIDE trial and the cancer diagnostics market
  • Industry Insights

NHS Launches World-First Multi-Cancer Blood Test Trial Across 200 GP Practices

Megan Wood2 weeks ago010 mins

Why early cancer detection is a market test case: the NHS STRIDE trial, £8.49m public funding and a diagnostics sector Acumen sizes at USD 142.3bn.

Read More
Measles cases USA November 2026: industry and vaccine demand after the New York child death
  • Industry Insights

New York Reports First Measles-Associated Child Death in Over 30 Years Amid Growing Outbreak

Megan Wood2 weeks ago012 mins

The latest measles cases USA November 2026 reports, led by a New York child death, raise questions for vaccine makers and public health budgets.

Read More
Narayana Health Q2 results FY27 graphic on organic versus acquired growth
  • Industry Insights

Narayana Health Q2 Results FY27: Revenue Up 73%, but Organic Growth Is 22.6% as UK Deal Dilutes Margins

Megan Wood2 weeks ago010 mins

The Narayana Health Q2 results FY27: 73% revenue growth, 22.6% without the UK. A business look at margins, finance costs and what to watch.

Read More
Rainbow Children Q2 FY27 results graphic on growth versus margin
  • Industry Insights

Rainbow Children’s Medicare Q2 FY27 Results: Revenue Up 23% as Expansion Squeezes Margins

Megan Wood2 weeks ago011 mins

The Rainbow Children Q2 FY27 results: revenue up 23%, profit up 11%. A business look at expansion costs, margins and what comes next.

Read More
Assam proton therapy centre graphic about financing and risks
  • Industry Insights

Assam Proton Therapy Centre: Financing, Utilisation and Execution Risks of a ₹600 Crore Public Project

Megan Wood2 weeks ago012 mins

The Assam proton therapy centre is a ₹600 crore public bet. Financing split, utilisation questions and execution risks.

Read More
India pharmaceutical market growth 2026 graphic about company winners
  • Industry Insights

India Pharmaceutical Market Growth 2026: Who Is Capturing the 12% Rise to ₹70,180 Crore

Megan Wood2 weeks ago2 weeks ago010 mins

Who captures India pharmaceutical market growth 2026? Sun, Torrent and Mankind outgrew the 12% market. Pricing and caveats.

Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 40

Categories

  • Healthcare IT (26)
  • Industry Insights (355)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
  • Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform
  • Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets
  • Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation
  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.